BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20424250)

  • 1. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial.
    House AA; Eliasziw M; Cattran DC; Churchill DN; Oliver MJ; Fine A; Dresser GK; Spence JD
    JAMA; 2010 Apr; 303(16):1603-9. PubMed ID: 20424250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
    ; Armitage JM; Bowman L; Clarke RJ; Wallendszus K; Bulbulia R; Rahimi K; Haynes R; Parish S; Sleight P; Peto R; Collins R
    JAMA; 2010 Jun; 303(24):2486-94. PubMed ID: 20571015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
    Toole JF; Malinow MR; Chambless LE; Spence JD; Pettigrew LC; Howard VJ; Sides EG; Wang CH; Stampfer M
    JAMA; 2004 Feb; 291(5):565-75. PubMed ID: 14762035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.
    Hankey GJ; Eikelboom JW; Yi Q; Lees KR; Chen C; Xavier D; Navarro JC; Ranawaka UK; Uddin W; Ricci S; Gommans J; Schmidt R;
    Lancet Neurol; 2012 Jun; 11(6):512-20. PubMed ID: 22554931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
    Albert CM; Cook NR; Gaziano JM; Zaharris E; MacFadyen J; Danielson E; Buring JE; Manson JE
    JAMA; 2008 May; 299(17):2027-36. PubMed ID: 18460663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy: Vitamin B6, B9 and B12 in diabetic nephropathy--beware.
    Thornalley PJ; Rabbani N
    Nat Rev Endocrinol; 2010 Sep; 6(9):477-8. PubMed ID: 20720587
    [No Abstract]   [Full Text] [Related]  

  • 9. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.
    Saposnik G; Ray JG; Sheridan P; McQueen M; Lonn E;
    Stroke; 2009 Apr; 40(4):1365-72. PubMed ID: 19228852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-vitamin therapy for diabetic nephropathy.
    Drion I
    JAMA; 2010 Aug; 304(6):636; author reply 636-7. PubMed ID: 20699452
    [No Abstract]   [Full Text] [Related]  

  • 11. B-vitamin therapy for diabetic nephropathy.
    Kadam S; Kulshrestha S; Swaminathan S
    JAMA; 2010 Aug; 304(6):636; author reply 636-7. PubMed ID: 20699451
    [No Abstract]   [Full Text] [Related]  

  • 12. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
    Ebbing M; Bleie Ø; Ueland PM; Nordrehaug JE; Nilsen DW; Vollset SE; Refsum H; Pedersen EK; Nygård O
    JAMA; 2008 Aug; 300(7):795-804. PubMed ID: 18714059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
    Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
    Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial.
    Borowczyk K; Piechocka J; Głowacki R; Dhar I; Midtun Ø; Tell GS; Ueland PM; Nygård O; Jakubowski H
    J Intern Med; 2019 Feb; 285(2):232-244. PubMed ID: 30193001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
    Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
    Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial.
    van Wijngaarden JP; Swart KM; Enneman AW; Dhonukshe-Rutten RA; van Dijk SC; Ham AC; Brouwer-Brolsma EM; van der Zwaluw NL; Sohl E; van Meurs JB; Zillikens MC; van Schoor NM; van der Velde N; Brug J; Uitterlinden AG; Lips P; de Groot LC
    Am J Clin Nutr; 2014 Dec; 100(6):1578-86. PubMed ID: 25411293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fortified spread on homocysteine concentration in apparently healthy volunteers.
    van Vliet T; Jacobs RG; de Deckere E; van den Berg H; de Bree A; van der Put NM
    Eur J Clin Nutr; 2007 Jun; 61(6):769-78. PubMed ID: 17151589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial.
    Zhang SM; Cook NR; Albert CM; Gaziano JM; Buring JE; Manson JE
    JAMA; 2008 Nov; 300(17):2012-21. PubMed ID: 18984888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease.
    Kang JH; Cook N; Manson J; Buring JE; Albert CM; Grodstein F
    Am J Clin Nutr; 2008 Dec; 88(6):1602-10. PubMed ID: 19064521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.